Literature DB >> 2023726

Long-term survival rate after vitreous surgery for complications of diabetic retinopathy.

S R Gollamudi1, W E Smiddy, A P Schachat, R G Michels, S Vitale.   

Abstract

The survival rate after vitreous surgery for complications of diabetic retinopathy was studied in 552 consecutive patients who underwent operations between 1979 and 1984. The 5-year postoperative survival rate was 74.7%. Factors associated with a lower survival rate included older age, older age at diagnosis of diabetes, history of renal disease, and a longer duration of diabetes. Factors unrelated to survival rate included insulin treatment, sex, and anatomic and visual outcome. Improved management of systemic diabetic complications has improved survival rates, a finding reflected in the relatively high rate of long-term survival after diabetic vitrectomy.

Entities:  

Mesh:

Year:  1991        PMID: 2023726     DOI: 10.1016/s0161-6420(91)32349-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.

Authors:  James Lin; Jonathan S Chang; William E Smiddy
Journal:  Ophthalmology       Date:  2016-07-15       Impact factor: 12.079

2.  Life expectancy of diabetic patients undergoing vitreous surgery.

Authors:  H Helbig; U Kellner; N Bornfeld; M H Foerster
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

3.  Long-term outcomes of vitrectomy for proliferative diabetic retinopathy.

Authors:  Vivian Schreur; Jody Brouwers; Ramon A C Van Huet; Sandra Smeets; Milan Phan; Carel B Hoyng; Eiko K de Jong; B Jeroen Klevering
Journal:  Acta Ophthalmol       Date:  2020-07-09       Impact factor: 3.761

4.  Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease.

Authors:  Abdah Khairiah Che Md Noor; Evelyn Li Min Tai; Yee Cheng Kueh; Ab Hamid Siti-Azrin; Zamri Noordin; Ismail Shatriah
Journal:  Int J Environ Res Public Health       Date:  2020-01-02       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.